Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intrathecal bupivacaine with dexmedetomidine in elderly patients undergoing proximal femoral fracture fixation
PACTR202403633859291Phase 2Recruiting
- Sponsor
- Mansoura University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bupivacaine and dexmedetomidine in anaesthesia (3 arms), sponsored by Mansoura University. Primary endpoint: time to first rescue analgesia dose. Started Feb 2024; status: recruiting.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
anaesthesia
Beyond the preview
Go deeper on PACTR202403633859291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202403633859291.